<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        36-498-14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2014
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ADVAQUIN 500MG FILM COATED TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LEVOFLOXACIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        40.4
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="OMAN PHARMACEUTICAL PRODUCTS" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            OMAN PHARMACEUTICAL PRODUCTS
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            OMAN PHARMACEUTICAL PRODUCTS
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01MA12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; What Advaquin tablets are and what they are used for</strong></p><p>The name of your medicine is Advaquin tablets. Advaquin tablets contain a medicine called levofloxacin. This belongs to a group of medicines called antibiotics. Levofloxacin is a &lsquo;quinolone&rsquo; antibiotic. It works by killing the bacteria that cause infections in your body.</p><p>Advaquin tablets can be used to treat infections of the:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sinuses</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lungs, in people with long-term breathing problems or pneumonia</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Urinary tract, including your kidneys or bladder</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prostate gland, where you have a long lasting infection</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin and underneath the skin, including muscles. This is sometimes called &lsquo;soft tissue&rsquo;</p><p>In some special situations, Advaquin tablets may be used to lessen the</p><p>chances of getting a pulmonary disease named anthrax or worsening of the</p><p>disease after you are exposed to the bacteria causing anthrax</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Before you take Advaquin tablets</strong></p><p>Do not take this medicine and tell your doctor if:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are allergic to levofloxacin, any other quinolone antibiotic such as moxifloxacin, ciprofloxacin or ofloxacin or any of the other ingredients of Advaquin tablets (listed in section 6 below)</p><p>Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have ever had epilepsy&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have ever had a problem with your tendons such as tendonitis that was related to treatment with a &lsquo;quinolone antibiotics&rsquo;. A tendon is the cord that joins your muscle to your skeleton</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are a child or a growing teenager</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are a pregnant, might become pregnant or think you may be pregnant</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are breast- feeding</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; at the first sign of tendon injury, such as tendon pain or swelling - rest the painful area;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you get pain, feel pins and needles, tingling, tickling, numbness or burning, or weakness especially in the legs or arms;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you get swelling in the shoulder, arms or legs, have walking difficulty, feel tired or depressed or have problems with your memory or with sleeping or you notice changes with your vision, taste, smell or hearing. You and your doctor will decide if you can continue treatment or if you need to take another type of antibiotic.</p><p>Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Advaquin tablets.</p><p>Warnings and precautions:</p><p>Take special care with Advaquin tablets check with your doctor or pharmacist before taking your medicine if:</p><p>-&nbsp; You have been diagnosed with an enlargement or &quot;bulge&quot; of a large blood vessel (aortic aneurysm or large vessel peripheral aneurysm</p><p>- You have experienced a previous episode of aortic dissection (a tear in the aorta wall).</p><p>- you have a family history of aortic aneurysm or aortic dissection or other risk factors or predisposing conditions (e.g. connective tissue disorders such as Marfan syndrome, or vascular Ehlers- Danlos syndrome, or vascular disorders such as Takayasu arteritis, giant cell arteritis, Behcet&rsquo;s disease, high blood pressure, or known atherosclerosis</p><p>- You feel sudden, severe pain in your abdomen, chest or back, go immediately to an emergency room.</p><p>- You may be more prone to joint pain or swelling or tendon damage or&nbsp; 60 years of age or older.</p><p>-&nbsp; You are using corticosteroids, sometimes called steroids (see &ldquo;taking other medicines&rdquo; below)</p><p>-&nbsp; You have ever had a fit (seizure)</p><p>-&nbsp; You have had damage to your brain due to a stroke or other brain injury</p><p>-&nbsp; You have kidney problems have received organ transplantation</p><p>- You have something known as &lsquo;glucose &ndash; 6 &ndash; phosphate dehydrogenase deficiency&rsquo;. You are more likely to have serious problems with your blood when taking this medicine</p><p>-&nbsp; You have ever had mental health problems</p><p>-&nbsp; You have ever had heart problems : caution should be taken when using this kind of medicine, if you were born with or have family history of prolonged QT interval (seen on ECG, electrical recording of the heart), have salt imbalance in the blood (especially low level of potassium or magnesium in the blood), have a very slow heart rhythm (called &lsquo;bradycardia&rsquo;), have a weak heart (heart failure), have a history of heart attack (myocardial infarction), you are female or elderly or you are taking other medicines that result in abnormal ECG changes or are taking vitamin K antagonists (e.g. warfarin), due to a possible increase in coagulation tests and/or bleeding (see section &ldquo;Taking other medicines&rdquo;).</p><p>-&nbsp; You are diabetic</p><p>- You have ever had liver problems</p><p>-&nbsp;&nbsp; You have myasthenia gravis.</p><p>If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking Advaquin tablets.</p><p>Children and adolescents</p><p>This medicine must not be given to children or teenagers</p><p>Taking other medicines</p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This includes medicines you buy without a prescription, including herbal medicines. This is because Advaquin tablets can affect the way some other medicines work. Also some medicines can affect&nbsp; the way Advaquin tablets work.</p><p>In particular, tell your doctor if you are taking any of the following medicines. This is because it can increase the chance of you getting side effects, when taken with Advaquin tablets:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corticosteroids, sometimes called steroids &ndash; used for inflammation. You may be more likely to have inflammation and/or breakage of your tendons.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vitamin K antagonists such as Warfarin &ndash; used to thin the blood. You may be more likely to have a bleed. Your doctor may need to take regular blood tests to check how well your blood can clot.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Theophylline &ndash; used for breathing problems. You are more likely to have a fit (seizure) if taken with Advaquin tablets</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non &ndash; steroidal anti &ndash; inflammatory drugs (NSAIDS) &ndash; used for pain and inflammation such as aspirin, ibuprofen, fenbufen, ketoprofen and indomethacin. you are more likely to have a fit (seizure) if taken with Advaquin tablets</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ciclosporin &ndash; used after organ transplants. You may be more likely to get the side effects of ciclosporin</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines known to affect the way your heart beats. This includes medicines used for abnormal heart rhythm (antiarrhythmics such as quinidine, hydroquinidine, disopyramide, sotalol, dofetilide, ibutilide and aminodarone), for depression (tricyclic antidepressants such as amitriptyline and imipramine), for psychiatric disorders (antipsychotics) and for bacterial infections (&lsquo;macrolide&rsquo; antibiotics such as erythromucin, azithromycin and clarithromycin).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Probenecid &ndash; used for gout, and cimetidine &ndash; used for ulcers and heartburn.&nbsp; Special care should be taken when taking either of these medicines with Advaquin. If you have kidney problems, your doctor may want to give you a lower dose.</p><p>Do not take Advaquin tablets at the same time as the following medicines. This is because it can affect the way Advaquin tablets work:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Iron tablets (for anemia), magnesium or aluminum &ndash; containing antacids (for acid or heartburn), didanesine or sulcralfate (for stomach ulcers). See section 3 &ldquo;if you are already taking iron tablets, antacids or sulcralfate&rdquo; below.</p><p>Urine tests for opiates</p><p>Urine tests may show &lsquo;false-positive &lsquo; results for strong painkillers called &lsquo;opiates&rsquo; in people taking Advaquin&nbsp; tablets. If your doctor is due to take a urine test, tell them you are taking Advaquin tablets.</p><p>Tuberculosis tests</p><p>This medicine may cause &ldquo;false negative&rdquo; results for some tests used in laboratory to search for the bacteria causing tuberculosis</p><p>Pregnancy and breast &ndash; feeding</p><p>Do not take this medicine if:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are pregnant, might become pregnant or think you may be pregnant</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are breast-feeding or planning to breast-feed ask your doctor or pharmacist for advice taking any medicine if you are pregnant or breast-feeding.</p><p>Driving and using medicines</p><p>You may get side effects after this medicine, including feeling dizzy, sleepy, a spinning feeling (vertigo) or changes to your eyesight. Some of these side effects can affect you being able to concentrate and your reaction speed. If this happens, do not drive or carry out any work that requires a high level of attention.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to take Advaquin tablets</p><p>Always take Advaquin tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p>Taking this medicine</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Take this medicine by mouth</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swallow the tablets whole with a drink of water</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The tablets may be taken during meals or at any time between meals</p><p>Protect your skin from sunlight</p><p>Keep out of direct sunlight while taking this medicine and for 2 days after</p><p>you stop taking it. This is because your skin will become much more sensitive to the sun and may burn, tingle or severely blister if you do not take the following precautions:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make sure you use high factor sun cream</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always wear a hat and cloths which cover your arms and legs</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Avoid sun beds</p><p>If you are already taking iron tablets, zinc supplements antacids, didanosine&nbsp; or sulcraflate</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not take these medicines at the same time as Advaquin. Take your dose at least 2 hours before or after Advaquin tablets</p><p>How much to take</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your doctor will decide on how many Advaquin tablets you should take</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The dose will depend on the type of infection is in your body</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The length of your treatment will depend on how serious your infection is</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you feel the effect of your medicine is too weak or strong do not change the dose yourself, but ask your doctor</p><p>Adults and the elderly</p><p>Sinuses Infection</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; One tablet of Advaquin 500mg, once each day Lungs infection, in people with long term breathing problems</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; one tablet of Advaquin 500mg, once each day Pneumonia</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; One tablet of Advaquin 500mg, once or twice each day Urinary tract, including your kidneys or bladder</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &frac12; tablet of Advaquin 500mg, each day Prostate gland infections</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; One tablet of Advaquin 500mg, once each day Skin and underneath the skin, including muscles</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &frac12; tablet or one tablet of Advaquin 500mg, once or twice each day Inhalation anthrax exposure</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; One tablet of Advaquin 500mg, once each day</p><p>Adults and the elderly with kidney problems</p><p>Your doctor may need to give you a lower dose.</p><p>Children and teenagers</p><p>This medicine must not be given to children or teenagers.</p><p>If you take more Advaquin tablets than you should</p><p>If you accidently take more tablets than you should, tell a doctor or get other medical advice straight away. Take the medicine pack with you. This is so the doctor knows what you have taken. The following effects may happen: convulsive fits (seizures), feeling confused, dizzy, less conscious and having tremor heart problems &ndash; leading to uneven heart beats as well as feeling sick (nausea) or having stomach burning.</p><p>If you forget to take Advaquin tablets</p><p>If you forgot to take a dose, take it as soon as you remember unless it is nearly time for your next dose. Do not double-up the next dose to make up for the missed dose.</p><p>If you stop taking Advaquin tablets</p><p>Do not stop taking Advaquin tablets just because you feel better. It is important that you complete the course of tablets that your doctor has prescribed for you. If you stop taking the tablets too soon, the infection may return, your condition may get worse or the bacteria may become resistant to the medicine.&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Possible side effects</strong></p><p>Like all medicines,&nbsp; Advaquin can cause side effects, although not everybody gets them. These effects are normally mild or moderate and often disappear after a short time.</p><p>Stop taking Advaquin tablets and see a doctor or go to a hospital straight away if you notice the following side effects:</p><p>Levofloxacin can cause long-lasting, disabling and potentially permanent side effects involving tendons, muscles, joints and the nervous system</p><p>These serious side effects include inflamed or torn tendon, muscle pain or weakness, and joint pain or swelling, walking difficulty, feeling pins and needles, burning pain, tiredness, depression, problems with memory, sleeping, vision and hearing, and altered taste and smell</p><p>Tendon swelling and injury may occur within 2 days of stalling treatment with a Levofloxacin but may even occur several months after stopping treatment</p><p>Not known (cannot be estimated from available data).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have an allergic reaction. The signs may include: a rash, swallowing or breathing problems, swelling of your lips, face, throat, or tongue.</p><p>Stop taking Advaquin tablets and see a doctor straight away if you notice any of the following serious side effects - you may need urgent medical treatment:</p><p>Rare (affects less than 1 person in 1000)</p><p>&bull; Fits (convulsions)</p><p>Not known (cannot be estimated from available data).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe skin rashes which may include blistering or peeling of the skin around your lips, eyes, mouth, nose and genitals</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of appetite, skin and eyes becoming yellow in colour, dark-coloured urine, itching, or tender stomach (abdomen). These may be signs of liver problems which may include a fatal failure of the liver.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Burning, tingling, pain or numbness. These may be signs of something called &lsquo;neuropathy&rsquo;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Watery diarrhea which may have blood in it, possibly with stomach cramps and a high temperature. These could be signs of a high temperature. These could be signs of a severe bowel problem</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain and inflammation in your tendons. The Achilles tendon is affected most often and in some cases, the tendon could break</p><p>If your eyesight becomes impaired or if you have any other eye disturbances</p><p>whilst taking Levofloxacin tablets, consult an eye specialist immediately.</p><p>Tell your doctor if any of the following side effects gets serious or lasts longer than a few days:</p><p>Common (affects less than 1 person in 10)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sleeping problems</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache, feeling dizzy</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling sick (nausea) and diarrhea</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in the level of some liver enzymes in your blood</p><p>Uncommon (affects less than 1 person in 100)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the number of other bacteria or fungi, infection by fungi named Candida, which may need to be treated</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the number of white blood cells shown up in the results of some blood tests (leukopenia, eosinophilia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling stressed (anxiety), feeling confused, feeling nervous, feeling sleepy, trembling, a spinning feeling (vertigo)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shortness of breath (dyspnoea)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the way things taste, loss of appetite, stomach upset or indigestion (dyspepsia), pain in your stomach area, feeling bloated</p><p>(flatulence) or constipation</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itching and skin rash, severe itching or hives (urticaria), sweating too much (hyperhidrosis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Joint pain or muscle pain</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood test may show unusual results due to liver (bilirubin increased) or kidney (creatinine increased)&nbsp; problems&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; General weakness</p><p>Rare (affects less than 1 person in 1000)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tingly feeling in your hands and feet (paraesthesia).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low number of white blood cells (called neutropenia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bruising and bleeding easily due to a lowering in the number of blood platelets (thrombocytopenia).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exaggerated immune response (hypersensitivity)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lowering of your blood sugar levels (hypoglycaemia). This is important for people that have diabetes.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Seeing or hearing things that are not there (hallucinations, paranoia),</p><p>change in your opinion and thoughts (psychotic reactions)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling depressed, mental problems, feeling restless (agitation), abnormal</p><p>dreams or nightmares.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Problems with your hearing (tinnitus) or eyesight (blurred vision).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unusual fast beating of your heart (tachycardia), awareness of your heartbeat (palpitation) or low blood pressure (hypotension).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle weakness. This is important in people with myasthenia gravis (a rare disease of the nervous system).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the way your kidney works and occasional kidney failure which may be due to an allergic kidney reaction called interstitial nephritis.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever</p><p>Very rare (affects less than 1 person in 10,000)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lowering in red blood cells (anaemia): this can make the skin pale or</p><p>yellow due to damage of the red blood cells; lowering in the number of all</p><p>types of blood cells (pancytopenia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased sensitivity of your skin to sun and ultraviolet light ( Photosensitivity)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of circulation (anaphylactic like shock)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the liver (hepatitis).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever, sore throat and a general of being unwell that does not go away. This may be due to a lowering in the number of white blood cells (agranulocytosis).&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase of your blood sugar levels (hyperglycaemia) or lowering of your blood sugar levels leading to coma (hypoglycaemic coma). This is important for people that have diabetes.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the way things smell, loss of smell or taste (parosmia, anosmia, ageusia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Problems moving and walking (dyskinesia, extrapyramidal disorders)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Temporary loss of consciousness or posture (syncope)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Temporary loss of vision</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impairment or loss of hearing</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal fast heart rhythm, life-threatening irregular heart rhythm including cardiac arrest, alteration of the heart rhythm (called &lsquo;prolongation of QT interval&rsquo;, seen on ECG, electrical activity of the heart).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difficulty breathing or wheezing (bronchospasm)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic lung reactions</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pancreatitis</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the vessels that carry blood around your body due to an allergic reaction (vasculitis)</p><p>&bull; Inflammation of the tissue inside the mouth (stomatitis)</p><p>&bull; Muscle rupture and muscle destruction (rhabdomyolysis)</p><p>&bull; Joint redness and swelling (arthritis)</p><p>&bull; Pain, including pain in the back, chest and extremities</p><p>&bull; Attacks of porphyria in people who already have porphyria (a very rare metabolic disease)</p><p>&bull; Persistent headache with or without blurred vision (benign intracranial hypertension)</p><p>&bull; Risk of having suicidal thoughts or actions</p><p>&nbsp;</p><p><strong>Reporting of side effect :</strong></p><p>If you get any side effect, talk to your doctor or pharmacist. This including any possible side effects not listed in this leaflet.</p><p>You can also report side effects directly.</p><p>( See details below).</p><p><strong>Oman:</strong></p><p>Department of Pharmacovigilance &amp; Drug Information</p><p>Directorate General of Pharmaceutical Affairs &amp; Drug Control, Ministry of Health</p><p>P.O.BOX: 393, Muscat, PC: 100, Sultanate of Oman</p><p>Phone: 22357688/ 22357687/ 22357686 Fax: 22358489;</p><p>Email: mohphar@omantel.net.om</p><p><strong>UAE:</strong></p><p>UAE Ministry of Health</p><p>Registration and Drug Control Department</p><p>Tel: 02 6117 389/329/391/318</p><p>Fax: 02 6313742 P.O. Box: 848 Abu Dhabi.</p><p>Email: pv@moh.gov.ae</p><p>Health Authority Abu Dhabi Pharmacovigilance Center</p><p>Telephone: 02 4193 586, 348, 580.</p><p>Facsimile: 02 4496679&nbsp; Email: pv@haad.ae</p><p><strong>SAUDI ARABIA:</strong></p><p>3292 Northern Ring Road &ndash; Alnafal</p><p>District. Riyadh 13312-6288 Fax: +966-1-205-7662</p><p>website: www.sfda.gov.sa E-mail: npc.drug@sfda.gov.sa</p><p><strong>Jordan Food and Drug Administration (JFDA):</strong></p><p>P.O.Box7704, Amman 11118, Jordan</p><p>(www.jfda.jo) or E-mail: jpc@jfda.jo</p><p>Ministry of Health Kuwait, Drug and Food Control:</p><p>(www.moh.gov.kw/kdfc)</p><p>Supreme council of health, pharmacy &amp; drug control</p><p><strong>State of Qatar :&nbsp;</strong></p><p>Ministry of Public Health</p><p>Pharmacy &amp; Drug Control Depatment</p><p>Web:(mop.gov.qa/health-services/Pages/pharmacy-n-drug-control.aspx)</p><p>Oman Pharmaceutical products Co. LLC.</p><p>(MAH &amp; Manufacturer). reg@omanpharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; How to store Advaquin tablets</p><p>Store below 30&deg;C.</p><p>Protect from light and moisture</p><p>Keep out of the reach of children.</p><p>Do not use Advaquin tablets after the expiry date (EXP) which is stated on the carton and foil.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Further information</p><p>What Advaquin tablets contain</p><p>The active ingredient is levofloxacin. Each tablet of Advaquin 500 mg tablets contains 500 mg of levofloxacin.</p><p>The other ingredients are:</p><p>Microcrystalline cellulose, maize starch, powdered cellulose, pregelatinized starch, crospovidone, povidone K-25, sodium stearyl fumarate, opadry pink and purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Advaquin tablets look and contents of the pack 
Advaquin tablets are film-coated tablets for oral use. Pink oblong, film coated tablets with break line on both faces.
Advaquin 500 mg tablets are provided in pack size 
(1 x 5’s) of 5 tablets.
Advaquin 500 mg tablets are provided in pack size 
(1 x 7’s) of 7 tablets.
Advaquin 500 mg tablets are provided in pack size 
(1 x 10’s) of 10 tablets.    
Not all pack sizes may be marketed. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder and Manufacturer</p><p>Oman Pharmaceutical Products Co., LLC</p><p>Salalah, Oman</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in January 2019
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>1- ما هي أقراص</strong><strong> </strong><strong>ادفاكوين</strong><strong> </strong><strong>وما وهي استخداماته؟</strong></p><p dir="RTL">اسم الدواء هو أقراص ادفاكوين.&nbsp; تحتوي الأقراص على دواء يسمى ليفوفلوكساسين.&nbsp; وهو ينتمي إلى مجموعة أدوية تدعى المضادات الحيوية . الليفوفلوكساسين هو مضاد حيوي من الكينولون يعمل عن طريق قتل البكتيريا التي تسبب الالتهابات في الجسم.<br /><br /><strong>ويمكن استخدام أقراص</strong><strong> </strong><strong>ادفاكوين </strong><strong>&nbsp;</strong><strong>لعلاج العدوى أو الالتهابات التالية:</strong></p><ul><li dir="RTL">الجيوب الأنفية</li><li dir="RTL">الرئتين، في الذين يعانون من مشاكل في التنفس على المدى الطويل أو الالتهاب الرئوي</li><li dir="RTL">المسالك البولية بما في ذلك المثانة أو الكلى.</li><li dir="RTL">غدة البروستات، في حالة الاصابة بالتهاب &nbsp;طويل الأمد.</li><li dir="RTL">الجلد وتحت الجلد، بما في ذلك العضلات.&nbsp;يسمى هذا أحيانا &quot;الأنسجة الرخوه&quot;</li></ul><p>في بعض الحالات الخاصة ، قد تستخدم أقراص &nbsp;ادفاكوين لتخفيف<br />فرص الحصول على مرض رئوي يسمى الجمرة الخبيثة أو تفاقم<br />المرض بعد تعرضك للبكتيريا المسببة لمرض الجمرة الخبيثة.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>2- قبل أن تأخذ أقراص</strong><strong> </strong><strong>ادفاكوين</strong><br /><br /><strong>لا تأخذ هذا الدواء، وأخبر الطبيب إذا</strong><strong>:</strong></p><ul><li dir="RTL">&nbsp;لديك حساسية من ليفوفلوكساسين، أو أي&nbsp; مضاد حيوي من مجموعة الكينولون كـ مكسيفلوكساسين و سيبروفوكساسين أو اوافلوكساين أو الى أي من المكونات الأخرى لأقراص الأدفاكوين (المدرجة ادناه في المادة رقم 6)<br />&nbsp;</li></ul><p dir="RTL">علامات الحساسية تشمل: طفح جلدي، صعوبة في البلع أو التنفس، تورم شفتيك والوجه والحلق أو اللسان</p><ul><li dir="RTL">إذا كان لديك صرع في أي وقت مضى .</li></ul><p dir="RTL">&nbsp;</p><ul><li dir="RTL">اذا كان لديك في&nbsp; وقت مضى مشكلة مع الأوتار الخاصه بك مثل التهاب&nbsp; الأوتار المرتبط بالعلاج بالمضادات الحيوية الكينولون &quot;.&nbsp;الوتر أو الأوتار هي الحبل الذي يربط عضلات الجسم الهيكل العظمي</li><li dir="RTL">اذا كنت طفلا في مرحلة&nbsp; المراهقة</li><li dir="RTL">اذا كنت حامل، قد تصبحين حاملا أو تعتقدين&nbsp; أنك قد تكون حاملا</li><li dir="RTL">اذا كنت مرضعة</li><li dir="RTL">في العلامة الاولي من أصابه وتر ، sucli كالم وتر أو تورم-بقية المنطقة المؤلمة.</li><li dir="RTL">&bull; إذا شعرت بالألم ، أو شعرت بالدبابيس أو الإبر ، أو وخز ، أو دغدغة ، أو خدر أو حرق ، أو ضعف خاص في الساقين أو الذراعين.</li><li dir="RTL">&bull; إذا كنت تتورم في الكتف أو الذراعين أو الساقين أو تعاني من صعوبة في المشي أو تشعر بالتعب أو الاكتئاب أو تعاني من مشاكل في الذاكرة أو النوم أو تلاحظ تغيرات في الرؤية أو الذوق أو الشم أو السمع. سوف تقرر أنت وطبيبك إذا كنت تستطيع متابعة العلاج أو إذا كنت بحاجة إلى أخذ نوع آخر من المضادات الحيوية.</li></ul><p dir="RTL"><br />لا تأخذ هذا الدواء إذا كان أي من الحالات المذكورة تنطبق عليك.&nbsp;إذا كنت غير متأكد،عليك التحدث إلى طبيبك أو الصيدلي قبل أخذ أقراص &nbsp;ادفاكوين.<br /><br />المحاذير والإحتياطات:</p><p dir="RTL">انتبه بعناية مع أقراص ادفاكوين استشر طبيبك أو الصيدلي قبل تناول الدواء إذا:<br /><strong>- </strong><strong>&nbsp;اذا </strong><strong>تم تشخيصك بتضخم أو &quot;انتفاخ&quot; في وعاء دموي كبير (الأورطى</strong><br /><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>تمدد الأوعية الدموية أو تمدد الأوعية الدموية الطرفية.</strong></p><p dir="RTL"><br /><strong>- </strong><strong>اذا كنت قد عانيت من حلقة سابقة من تشريح الأبهر (تمزق في جدار الأبهر</strong><strong>).</strong></p><p dir="RTL"><br /><strong>- </strong><strong>&nbsp;اذا كان </strong><strong>لديك تاريخ عائلي من أم الدم الأبهرية أو تشريح الأبهر أو عوامل الخطر الأخرى أو</strong></p><p dir="RTL"><br /><strong>الظروف المؤهبة (مثل اضطرابات النسيج الضام مثل متلازمة مارفان أو متلازمة الألفرس أو إيللوس أو الاضطرابات الوعائية مثل الشرايين التاكاياسو أو الشرايين العملاقة في الخلايا أو مرض بهجت أو ارتفاع ضغط الدم أو تصلب الشرايين المعروف.</strong></p><p dir="RTL"><br /><strong>- </strong><strong>&nbsp;اذا كنت </strong><strong>تشعر بألم مفاجئ وخيم في البطن أو الصدر أو الظهر ، اذهب فوراً إلى غرفة الطوارئ</strong><strong>.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><ul><li dir="RTL">قد تكون أكثر عرضة لألم المفاصل أو تورم أو تلف الأوتار اذا كنت تبلغ 60 سنة من العمر أو أكثر.</li><li dir="RTL">اذا كنت &nbsp;تستخدم ستيرويدات قشرية، ويطلق عليه أحيانا ستيرويد (راجع &quot;الاستعمال مع أدوية اخرى&quot; أدناه)</li><li dir="RTL">اذا لديك صرع في أي وقت مضى</li><li dir="RTL">اذا لديك تلف في الدماغ بسبب السكتة الدماغية أو غيرها من الإصابات الدماغية</li><li dir="RTL">اذا لديك مشاكل في الكلى او كنت قد تلقيت زرع الأعضاء.</li><li dir="RTL">اذا لديك ما يسمي بـ نازعة نقص جلوكوز - 6 - فوسفات . فانه من المحتمل أن يكون لها مشاكل خطيرة في الدم عند تناول هذا الدواء</li><li dir="RTL">اذا لديك مشاكل سابقة في الصحة العقلية</li><li dir="RTL">لديك مشاكل سابقة في القلب: يجب ان تاخذ الحذر عند استخدام هذا النوع من الأدوية ، إذا كنت قد ولدت مع أو لديك تاريخ عائلي لفترات طويلة من QT (انظر على تخطيط القلب الكهربائي ، والتسجيل الكهربائي للقلب) ، ولديك خلل في الملح في الدم (خاصة انخفاض مستوى البوتاسيوم أو المغنيسيوم في الدم)، لديهم إيقاع بطيء جدًا في القلب (يسمى &quot;بطء القلب&quot;) ، لديهم ضعف في القلب (فشل القلب) ، لديهم تاريخ من النوبات القلبية (احتشاء عضلة القلب) ، أنت أنثى أو مسن أو كنت تأخذ أدوية أخرى ينتج عنها تغييرات ECG غير طبيعية أو أخذ مضادات فيتامين K (مثل الوارفارين) ، بسبب زيادة محتملة في اختبارات التخثر و / أو النزيف (انظر القسم &quot;تناول أدوية أخرى&quot;).</li><li dir="RTL">اذا كنت مصاب بالسكري</li><li dir="RTL">اذا لديك مشاكل سابقة في الكبد</li><li dir="RTL">اذا لديك الوهن العضلي الوبيل.<br /><br />إذا لم تكن متأكدا مما اذا كان أي من المذكور أعلاه ينطبق عليك، يرجى التحدث إلى الطبيب أو الصيدلي قبل أخذ أقراص ادفاكوين.<br /><br /><strong>أخذ أدوية أخرى</strong><br /><br />يرجى إخبار الطبيب أو الصيدلي إذا كنت تأخذ أو أخذت في الآونة الأخيرة أي أدوية أخرى.&nbsp;وهذا يشمل الأدوية التي تشترى دون وصفة طبية، بما في ذلك الأدوية العشبية. هذا&nbsp;لأن أقراص &nbsp;ادفاكوين يمكن أن تؤثر على طريقة عمل بعض الأدوية الأخرى. كما يمكن لبعض الأدوية تؤثر على طريقة عمل أقراص ادفاكوين.<br /><br /><strong>على وجه الخصوص، أخبر طبيبك إذا كنت تأخذ أي من الأدوية التالية</strong><strong>.&nbsp;</strong><strong>وذلك لأنه يمكن أن تزيد من فرص ظهور الآثار الجانبية ، عندما تؤخذ مع اقراص ادفاكوين </strong></li><li dir="RTL">الستيرويدات القشرية، ويطلق عليها أحيانا ستيرويد - تستخدم في حالة الالتهاب.&nbsp;قد تؤدي الى أكثر عرضة للالتهاب و / أو تكسر في الأوتار.</li><li dir="RTL">&nbsp;&nbsp;مضادات فيتامين ك مثل الوارفارين - تستخدم لزيادة سيولة الدم .&nbsp; قد يؤدي الى حدوث نزف قد يحتاج الطبيب إلى إجراء فحوص دم دورية للتأكد من مدى تجلط الدم<strong>.</strong></li><li dir="RTL">الثيوفيلين - تستخدم لمشاكل التنفس . في حالة إستخدامها مع أقراص أدفاكوين قد يؤدي الى إمكانية حصول نوبات صرع.</li><li dir="RTL">الأدوية الغيرستيرويدية والمضادو للإلتهابات - (المسكنات) - تستخدم في حالة الألم &nbsp;و الالتهاب مثل، الأسبرين الإيبوبروفين، كيتوبروفين، فينبوفين والإندوميتاسين.&nbsp;قد تؤدي الى التعرض لنوبات صرع إذا ما تم تناولها مع أقراص الادفاكوين.</li><li dir="RTL">السيكلوسبورين - يستخدم بعد عمليات زرع الأعضاء.&nbsp;قد تزيد من احتمال الحصول على الآثار الجانبية لـ السيكلوسبورين</li><li dir="RTL">الأدوية المعروفة بتأثيرها على نبضات القلب.&nbsp;وهذا يشمل الأدوية المستخدمة لعلاج ضربات القلب الغير طبيعية) مضادات إضطرابات نظم القلب مثل كينيدين، هيدروكينيدين ، ديسبيوراميد ، سوالول ، دوفيتيليدي ، ابتيليدي و الاميودرون)، والادوية المضادة لـ<br />الاكتئاب (مضادات الاكتئاب ثلاثية الحلقات مثل أميتريبتيلين وإيميبرامين) لاضطرابات نفسية (مضادات النفسية)والادوية المستخدمة للعدوى الجرثومية (المضادات الحيوية ماكرولايد مثل الايريثروميسين و ، وأزيثروميسين<br />كلاريثروميسين)</li><li dir="RTL">بروبنيسيد - تستخدم لمرض النقرس، والسيميتيدين - يستخدم لعلاج قرحة وحرقة المعدة. يجب أخذ الحيطة إذا ما تم تناول أقراص الادفاكوين مع أي من هذه الأدوية.&nbsp;إذا كانت لديك مشاكل في الكلى، فإن طبيبك قد يصف لك جرعة أقل.<br /><br /><strong>لا تأخذ أقراص الادفاكوين في نفس الوقت مع الأدوية التالية وذلك لأنها يمكن أن تؤثر على طريقة عمل اقراص&nbsp; ادفاكوين</strong><strong>:</strong></li><li dir="RTL"><strong>&nbsp;</strong></li><li dir="RTL">&nbsp;أقراص الحديد (لفقر الدم)، ومضادات الحموضة - التي تحتوي على المغنيسيوم أو الألمنيوم&nbsp; (للحموضة أوحرقة المعدة)، ديدانيسيين أو <strong>سولكرالفيت</strong> لقرحة المعدة.(&nbsp;انظر القسم 3 أدناه &quot;إذا كنت بالفعل تأخذ<br />أقراص الحديد، ومضادات الحموضة أوسولكرالفيت).<br /><br /><strong>اختبارات البول للمواد الأفيونية</strong><br /><br />اختبارات البول يمكن تظهر نتائج &quot;إيجابية كاذبة&quot; عن &nbsp;وجود مسكنات قوية وتدعى &nbsp;&#39;مستحضرات الأفيون&#39; في الناس الذين يأخذون الادفاكوين.&nbsp;إذا كان طبيبك &nbsp;أمر بإجراء اختبار البول، اخبره بأنك تأخذ أقراص ادفاكوين<strong>.</strong></li></ul><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>اختبارات السل</strong></p><p dir="RTL"><strong>قد يسبب هذا الدواء نتائج &quot;سلبية خاطئة&quot; لبعض الاختبارات المستخدمة في المختبر للبحث عن البكتيريا المسببة لمرض السل.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل والرضاعة&nbsp; </strong><br /><br />لا تأخذ هذا الدواء في الحالات التالية:</p><ul><li><ul><li dir="RTL">اذا كنت حامل، قد تصبحين حاملا أو تعتقدين أنك قد تكونين حاملا</li><li dir="RTL">اذا كنت مرضعة&nbsp; طبيعيا أو تخططين لذلك إسألي طبيبك أو الصيدلي للحصول على<br />نصيحة قبل اخذ أي دواء إذا أنت حاملا أوفي وقت الرضاعة الطبيعية.<br />&nbsp;</li></ul></li></ul><p><strong>القيادة واستخدام الأليات</strong><br /><br />قد تحصل آثار جانبية بعد اخذ هذا الدواء، ومنها الشعور بالدوار، والنوم، والشعور بالدوران<br />تغييرات في البصر.&nbsp;يمكن لبعض من هذه الآثار الجانبية تؤثر على قدرتك على التركيز وسرعة رد الفعل لديك. .&nbsp;إذا حدث هذا، لا تقوم&nbsp; بتأدية أي من الأعمال التي تتطلب مستوى عاليا من الاهتمام.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><br /><strong>3. </strong><strong>&nbsp;</strong><strong>كيف تأخذ أقراص ادفاكوين</strong><br /><br />قم بأخذ أقراص أدفاكوين دائما حسب تعليمات الطبيب بالضبط . يجب عليك أن التحقق مع<br />طبيبك أو الصيدلي إذا كنت غير متأكد.<br /><br /><strong>تناول هذا الدواء</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>يؤخذ هذا الدواء عن طريق الفم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ابتلاع أقراص كاملة مع شربة ماء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن أخذ الأقراص مع &nbsp;وجبات الطعام أو في أي وقت بين الوجبات<br />&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>حماية البشرة من أشعة الشمس</strong><br /><br />تجنب أشعة الشمس المباشرة أثناء تناول هذا الدواء ولمدة يومين<br />بعد توقف عن أخذ الدواء.لأن جلدك سوف يصبح<br />حساس كثيرا لأشعة الشمس ومما قد يؤدي الحرق، والشعور بالوخز أو ظهور علامات حرق&nbsp; إذا لم تأخذ في بعد الاحتياطات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تأكد من استخدامك لكريم مضاد لأشعة الشمس عالي الفعالية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتدي دائما قبعة والملابس التي تغطي ذراعيك وساقيك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تجنب أسرّة تسمير البشرة.</p><p dir="RTL"><br /><strong>إذا كنت تستخدم أقراص الحديد ،</strong> <strong>مكملات الزنك ، مضادات الحموضة</strong><strong> </strong><strong>،</strong> <strong>ديدانوزين أو سولكرالفيت</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تأخذ هذه الأدوية في نفس الوقت &nbsp;مع ادفاكوين يجب ان تأخذ الجرعة بما لا يقل عن ساعتين &nbsp;قبل أو بعد أقراص ادفاكوين.</p><p dir="RTL"><br /><strong>كم قرص تأخذ</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طبيبك سوف يقرر كم قرص من ادفاكوين يجب أن تأخذ</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة تعتمد على نوع العدوى المصاب بها في جسمك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طول فترة العلاج الخاصه بك تعتمد على مدى خطورة الاصابة لديك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا شعرت أن &nbsp;تأثير الدواء قوي جدا أو ضعيف لا تغير الجرعة بنفسك، ولكن اسأل طبيبك</p><p dir="RTL">&nbsp;</p><p dir="RTL"><br /><strong>البالغين وكبار السن</strong><br /><strong>الجيوب الانفية أو العدوى :</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حبة واحدة من اقراص ادفاكوين 500 ملجم ، مرة واحدة يوميا</p><p dir="RTL"><br /><strong>عدوى الرئتين، في الاشخاص مع مشاكل في التنفس طويلة الأجل</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حبة واحدة من اقراص ادفاكوين 500 ملجم ، مرة واحدة يوميا</p><p dir="RTL"><br /><br /><strong>الالتهاب الرئوي</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حبة واحدة من اقراص ادفاكوين 500 ملجم ، مرة&nbsp; أو مرتين يوميا</p><p dir="RTL"><br /><br /><strong>المسالك البولية بما في ذلك المثانة أو الكلى </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نصف حبة من اقراص ادفاكوين 500 ملجم ، مرة واحدة يوميا</p><p dir="RTL">&nbsp;<br /><br />عدوى الغدة البروستاتية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حبة واحدة من اقراص ادفاكوين 500 ملجم ، مرة واحدة يوميا</p><p dir="RTL"><br /><br /><strong>الجلد وتحت الجلد، بما في ذلك العضلات</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نصف حبة أو حبة واحدة من اقراص ادفاكوين 500 ملجم ، مرة&nbsp; أو مرتين يوميا</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>التعرض للانثراكس الاستنشاق</strong></p><p dir="RTL">&bull; قرص واحد من ادفاكوين 500 ملجم ، مرة واحدة كل يوم.</p><p dir="RTL"><br /><br /><strong>البالغين والمسنين الذين يعانون من مشاكل في الكلى</strong></p><p dir="RTL">طبيبك قد يحتاج لإعطائك جرعة أقل.<br /><br /><strong>الأطفال والمراهقين</strong><br /><br />يجب ألا يعطى هذا الدواء للأطفال أو المراهقين.<br /><br /><strong>إذا أخذت اقراص ادفاكوين أكثر من الجرعة &nbsp;المصروفه لك:</strong><br /><br />إذا أخذت اقراص زائدة عن الجرعة عن طريق الخطأ ، أخبر الطبيب أو الحصول على المشورة الطبية الأخرى على الفور.&nbsp;خذ عبوة الدواء معك.&nbsp;هذا حتى يتمكن الطبيب من معرقة ما أخذت. الآثار التالية قد تحدث اعقاب ذلك : نوبات تشنج (صرع)، والشعور بالارتباك، والدوار،<br />الشعور بقلة الوعي ووجود الهزة مشاكل في القلب - مما يؤدي إلى نبضات قلب متفاوتة، فضلا عن الشعور بالغثيان أو حرق المعدة.</p><p dir="RTL">&nbsp;</p><p><strong>إذا كنت قد نسيت أن تأخذ أقراص &nbsp;ادفاكوين</strong><br /><br />إذا كنت قد نسيت أن تأخذ جرعة، خذ الجرعة &nbsp;بمجرد أن تتذكر ما لم يكن الوقت قد حان تقريبا للجرعة المقبلة.&nbsp;لاتأخذ جرعتين في نفس الوقت لتعويض الجرعة الفائتة.<br /><br /><strong>إذا توقفت عن تناول حبوب ادفاكوين</strong><br /><br />لا تتوقف عن تناول أقراص ادفاكوين فقط لأنك تشعر بتحسن.&nbsp;فمن المهم أن تقوم بإكمال &nbsp;الدورة الكاملة للأقراص حسب ما تم صرفه من قبل الطبيب لك .إذا قمت&nbsp; بالتوقف عن تناول<br />الأقراص قبل أوانه، قد تعود العدوى ، وقد تزداد حالتك سوءا وقد تصبح البكتيريا قد<br />تصبح مقاومة لدواء.<br /><br />إذا كان لديك أي أسئلة أخرى على استخدام هذا الدواء، اسأل طبيبك أو الصيدلي.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><br /><strong>4. </strong><strong>&nbsp;</strong><strong>الآثار الجانبية المحتملة</strong><br /><br />كما هو الحال مع معظم الأدوية، يمكن للادفاكوين أن &nbsp;يسبب آثارا جانبية، على الرغم من أن لا تظهر على جميع المتعاطين للدواء. هذه التأثيرات خفيفة أو معتدلة، وغالبا ما تختفي عادة بعد وقت قصير.<br /><br /><strong>توقف عن تناول أقراص</strong><strong> </strong><strong>ادفاكوين</strong><strong> </strong><strong>وقم بمراجعة الطبيب أو الذهاب الى المستشفى على الفور إذا لاحظت أي من الآثار الجانبية التالية:</strong></p><p dir="RTL">غير معروف (لا يمكن تقديره من البيانات المتاحة)</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">يمكن أن يتسبب الليفوفلوكساسين في حدوث آثار جانبية طويلة الأمد ومعيقة وربما دائمة بما في ذلك الأوتار والعضلات والمفاصل والجهاز العصبي</p><p dir="RTL">وتشمل هذه الآثار الجانبية الخطيرة التهاباً أو تمزقًا في الوتر وألمًا في العضلات أو ضعفًا ، وألمًا في المفصل أو تورمًا ، وصعوبة في المشي ، وشعورًا بالدبابيس والإبر ، وحرقة الألم ، والتعب ، والاكتئاب ، ومشاكل في الذاكرة ، والنوم ، والرؤية ، والسمع ، وتغيير الذوق رائحة</p><p dir="RTL">قد يحدث التورم والإصابة في الوتر خلال يومين من المعالجة الموقفة مع ليفوفلوكساسين ولكن قد يحدث بعد عدة أشهر من التوقف عن العلاج.</p><p dir="RTL"><br />اذا كان لديك رد الفعل التحسسي ، وهذا قد يشمل علامات منها: طفح جلدي، مشاكل في &nbsp;البلع أو التنفس ، وتورم في الشفاه والوجه والحلق، أو اللسان</p><p dir="RTL"><br /><strong>توقف عن تناول أقراص</strong><strong> </strong><strong>ادفاكوين</strong><strong> </strong><strong>وقم بمراجعة الطبيب فورا إذا لاحظت أي من الآثار الجانبية الخطيرة - قد تحتاج إلى علاج طبي عاجل</strong><strong>:</strong><br /><br /><strong>نادر</strong> (تؤثر على أقل من 1 شخص في كل 1000 شخص)</p><p dir="RTL">&bull; نوبات (التشنجات)</p><p dir="RTL">غير معروف (لا يمكن تقديره من البيانات المتاحة).</p><p dir="RTL">&bull; الطفح الجلدي الشديد الذي قد يشمل تقرحات أو تقشير الجلد حول الشفاه والعيون والفم والأنف والأعضاء التناسلية.</p><p dir="RTL">&bull; فقدان الشهية ، والجلد والعين تصبح صفراء اللون ، والبول داكن اللون ، والحكة ، أو المعدة الطرية (البطن). قد تكون هذه علامات على مشاكل في الكبد والتي قد تشمل فشلًا فادحًا في الكبد.</p><p dir="RTL">&bull; الحرق أو الوخز أو الألم أو التنميل. قد تكون هذه علامات على شيء يسمى &quot;اعتلال الأعصاب&quot;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال المائي (شديد السيوله) قد يكون مصاحب بدم، مع تقلصات فى المعدة، و ارتفاع في درجات الحرارة.&nbsp;يمكن أن تكون هذه دلائل على وجود ارتفاع في درجة الحرارة.&nbsp;وقد تكون هذه علامات تشير إلى مشكلة حادة في الأمعاء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;ألم والتهاب في الأوتار.&nbsp; وتر العرقوب في كثير من الأحيان الأكثر تضررًا<br />وفي بعض الحالات، يمكن أن يؤدي الى &nbsp;تكسر الوتر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالة ضعف البصر أو إذا كان لديك أي اضطرابات أخرى في العين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أثناء تناول أقراص ليفوفلوكساسين ، استشر طبيب العيون على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><br /><strong>أخبر طبيبك إذا كان أي من الآثار الجانبية التالية&nbsp; ازدات سوءا أو استمرت لفترة أطول عدة ايام</strong><strong>:</strong><strong> </strong><br /><strong>الشائعة </strong>(يؤثر على أقل من 1 شخص في 10 اشخاص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل النوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع ، الشعور بالدوار</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالمرض (الغثيان) والإسهال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في مستوى بعض انزيمات الكبد في الدم</p><p dir="RTL"><br /><strong>من غير المألوف</strong> (يؤثر على أقل من 1 شخص في كل 100 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغيرات في عدد البكتريا أو الفطريات الأخرى ، العدوى بالفطر المسمى كانديدا والتي قد تحتاج إلى علاج.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغيرات في عدد كريات الدم البيضاء التي ظهرت في نتائج بعض اختبارات الدم (الكريات البيض ، فرط الحمضات).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; الشعور بالإجهاد (القلق) ، الشعور بالارتباك ، الشعور بالتوتر ، الشعور بالنعاس ، الارتعاش ، الشعور بالدوار (الدوار)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق في التنفس (ضيق النفس)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغييرات في طريقة تذوق الأشياء ، وفقدان الشهية ، واضطراب المعدة أو عسر الهضم (عسر الهضم) ، والألم في منطقة المعدة ، والشعور بالانتفاخ</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (انتفاخ البطن) أو الإمساك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحكة والطفح الجلدي ، الحكة الشديدة أو خلايا (الشرى) ، التعرق أكثر من اللازم (فرط التعرق)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;آلام المفاصل أو العضلات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;قد يظهر اختبار الدم نتائج غير عادية بسبب زيادة الكبد (زيادة البيليروبين) أو مشاكل الكلى (زيادة الكرياتينين)</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>نادر</strong> (يؤثر على أقل من 1 شخص في كل 1000شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بوخز في اليدين والقدمين (مذل)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد خلايا الدم البيضاء (يدعى نيتروبنيا)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حصول الكدمات والنزيف بسهولة بسبب انخفاض عدد الصفائح الدموية (نقص الصفيحات الدموية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; استجابة مناعية مبالغ فيها (فرط الحساسية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستوى السكر في الدم (نقص سكر الدم). هذا مهم للناس الذين لديهم مرض السكري.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رؤية أو سماع أشياء غير موجودة (الهلوسة ، جنون الشك) ،تغيير في رأيك وأفكارك (ردود فعل ذهانية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;الشعور بالاكتئاب ، ومشاكل عقلية ، والشعور بالقلق (الإثارة) ، غير طبيعي أحلام أو كوابيس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;مشاكل في السمع (الطنين) أو البصر (عدم وضوح الرؤية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;ضربات قلب سريعة&nbsp; (عدم انتظام دقات القلب) ، والوعي الخاص بك ضربات القلب (خفقان) أو انخفاض ضغط الدم (انخفاض ضغط الدم).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;ضعف العضلات. هذا مهم في الأشخاص الذين يعانون من الوهن العضلي الوبيل (أمرض نادر من الجهاز العصبي).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغييرات في الطريقة التي تعمل بها الكلية والفشل الكلوي العرضي قد يكون ناجما عن رد فعل تحسسي في الكلى يسمى التهاب الكلية الخلالي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادر جدا</strong> (يؤثر على أقل من 1 شخص في كل 10،000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في خلايا الدم الحمراء (فقر الدم): هذا يمكن أن يجعل البشرة شاحبة&nbsp; أو</p><p dir="RTL">صفراء بسبب تلف خلايا الدم الحمراء. انخفاض في عدد الجميع أنواع خلايا الدم (قلة الكريات الشاملة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة حساسية الجلد لأشعة الشمس والأشعة فوق البنفسجية (الحساسية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقد دوران&nbsp; الدم في الجسم &nbsp;(مثل الصدمة تأقية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;التهاب الكبد ( التهاب الكبد).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;الحمى والتهاب الحلق الشعور بشكل عام بتعب مستمر.&nbsp;قد يكون هذا بسبب نقص في عدد خلايا الدم البيضاء.( ندرة المحببات)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستوى السكر في الدم أو خفض من مستوى السكر في الدم تؤدي إلى غيبوبة (غيبوبة نقص سكر الدم). هذا هومهم للأشخاص الذين يعانون من مرض السكري.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;التغييرات في طريقة رائحة الأشياء ، وفقدان الرائحة أو التذوق</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في الحركة والمشي (خلل في الحركة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان مؤقت للوعي أو الموقف (الإغماء)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان مؤقت للرؤية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض أو فقدان السمع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;عدم انتظام ضربات القلب بشكل طبيعي ، وتهديد القلب غير المنتظم الذي يهدد الحياة ، بما في ذلك السكتة القلبية ، وتغيير إيقاع القلب (يُسمى &quot;إطالة فترة QT&quot; ، يُشاهد على تخطيط كهربية القلب ، النشاط الكهربائي للقلب)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في التنفس أو الصفير اثناء التنفس (تشنج قصبي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حساسية الرئة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب البنكرياس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأوعية التي تحمل الدم في جميع أنحاء جسمك بسبب تفاعل تحسسي (التهاب الأوعية الدموية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأنسجة داخل الفم (التهاب الفم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تمزق العضلات وتدمير العضلات (انحلال الربيدات)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احمرار وتورم المفاصل (التهاب المفاصل)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم ، بما في ذلك ألم في الظهر والصدر والأطراف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هجمات البورفيريا في الأشخاص الذين لديهم بالفعل البورفيريا (نادرة جدا<br />مرض استقلابي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع مستمر مع أو بدون تشوش الرؤية (داخل الجمجمة الحميدة<br />ارتفاع ضغط الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خطر وجود أفكار أو أعمال انتحارية</p><p dir="RTL"><br /><strong>الإبلاغ عن الآثار الجانبية:</strong></p><p dir="RTL">إذا حصل لك أي أثر جانبي ،اخبر طبيبك أو الصيدلي.</p><p dir="RTL">هذا بما في ذلك أي اثار جانبية محتملة حدوثها غير مذكورة في هذه النشرة .</p><p dir="RTL">يمكنك أيضا الإبلاغ عن الآثار الجانبية مباشرة ( انظر التفاصيل أدناه).</p><p dir="RTL"><strong>سلطنة عمان :</strong></p><p dir="RTL">قسم الصيدلية الدوائية و المعلومات الدوائية</p><p dir="RTL">المديرية العامة للشؤون الصيدلية و مكافحة المخدرات بوزارة الصحة</p><p dir="RTL">صندوق البريد :393 ، مسقط ،رمز البريد :100 ، سلطنة عمان</p><p dir="RTL">الهاتف :22357688 /22357687 /22357686 الفاكس :22358489</p><p dir="RTL">البريد الالكتروني : mohphar@omantel.net.om</p><p dir="RTL">ا<strong>لامارات العربية المتحدة:</strong></p><p dir="RTL">وزارة الصحة الاماراتية</p><p dir="RTL">إدارة التسجيل و مراقبة المخدرات</p><p dir="RTL">389611702/329/391/318 الهاتف : الفاكس :026313742</p><p dir="RTL">صندوق البريد :484 أبو ظبي</p><p dir="RTL">البريد الالكتروني : pv@moh.gov.ae</p><p dir="RTL"><strong>هيئة الصحة مركز أبو ظبي للوقوف الدوائية</strong></p><p dir="RTL">الهاتف : 586419302،348،580 الفاكس :449667902</p><p dir="RTL">البريد الالكتروني : pv@haad.ae</p><p dir="RTL"><strong>المملكة العربية السعودية</strong></p><p dir="RTL">3292 طريق الدائري الشمالي &ndash; النفل</p><p dir="RTL">منطقة ،الرياض 13312-6288 فاكس :+966-1-205-7662</p><p dir="RTL">Website: www.sfda.gov.sa</p><p dir="RTL">البريد الإلكتروني : npc.drug@sfd.gov .sa</p><p dir="RTL"><strong>الاردن:</strong></p><p dir="RTL"><strong>(JFDA)&nbsp; </strong>إدارة الغذاء و الدواء الأردنية</p><p dir="RTL">صندوق البريد: 7704 ، عمان 11118 ، الاردن</p><p dir="RTL">www.moh.gov.kw/kdfc (</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>مملكة البحرين:</strong></p><p dir="RTL">(NHRA)الهيئة الوطنية لتنظيم الصحة</p><p dir="RTL">رقم المبنى0242 ، رقم الشارع :2831 ،رقم القطعة :428</p><p dir="RTL">منطقة السيف ، صندوق البريد :11464 ، المنامة ، مملكة البحرين</p><p dir="RTL">(www.moh.gov.bh)</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الكويت</strong></p><p dir="RTL"><strong>وزارة الصحة الكويت ، مكافحة المخدرات و الغذاء .</strong></p><p dir="RTL"><strong>(www.moh.gov.kw/kdfc)</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>قطر</strong></p><p dir="RTL">المجلس الأعلى للصحة و الصيدلة و مكافحة المخدرات قسم دولة قطر</p><p dir="RTL">(www.moph.gov.qa/pharmacy-n-drug-control).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><br />5<strong>. </strong><strong>&nbsp;كيفية تخزين أقراص ادفاكوين</strong><br /><br />تخزن في درجة حرارة &nbsp;أقل من 30 درجة مئوية.<br /><br />بعيدا عن الضوء والرطوبة<br /><br />تبقي بعيدا عن متناول الأطفال.<br /><br />لا تستخدم أقراص ادفاكوين بعد تاريخ انتهاء الصلاحية (EXP) المذكور على العبوة الكرتونية &nbsp;والشريط .<br /><br />الأدوية يجب أن ألا يتم التخلص منها عن طريق مياه الصرف الصحي أو النفايات المنزلية.&nbsp;اسأل<br />الصيدلي كيفية التخلص من الأدوية التي لم تعد مطلوبة.&nbsp;وسيساعد ذلك على تدابير حماية البيئة.<br /><br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>6. </strong><strong>&nbsp;</strong><strong>مزيد من المعلومات</strong><br /><br /><strong>على ماذا تحتوي اقراص ادفاكوين </strong><br /><br />العنصر النشط ليفوفلوكساسين.&nbsp;كل حبة من ادفاكوين 500 ملجم تحتوي على 500 ملجم من ليفوفلوكساسين.<br /><br />المكونات الأخرى هي:<br /><br />ميكروكرستالين السيلولوز، نشا الذرة، مسحوق السليلوز والنشا، بريجيلاتينايزد كرسبوفيدون (pregelatinized crospovidone ) البوفيدون K-25، الصوديوم ستياريلي فومارات، اوبدري الوردي والمياه النقية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><br /><strong>ما</strong><strong> </strong><strong>هو</strong><strong> </strong><strong>شكل أقراص ادفاكوين ومحتويات العبوة </strong><br /><br />أقراص أدفاكوين هي أقراص مغلفة بفيلم للاستخدام عن طريق الفم.&nbsp;أقراص وردية اللون مستطيلة الشكل مغلفه بفيلم مع وجود &nbsp;خط فاصل في منتصف القرص من كلا الجهتين.<br /><br />أقراص ادفاكوين500 ملجم&nbsp; توجد في عبوة تحتوي على شريط من 5 اقراص</p><p dir="RTL">أقراص ادفاكوين500 ملجم&nbsp; توجد في عبوة تحتوي على شريط من 7 اقراص</p><p dir="RTL">أقراص ادفاكوين500 ملجم&nbsp; توجد في عبوة تحتوي على شريط من 10 اقراص</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>حامل ترخيص التسويق والمصنّع</strong><br />الشركة العمانية لمستحضرات الصيدلة ش م م<br />صلالة، سلطنة عمان</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
تمت مراجعة هذه النشرة في يناير 2019

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1.	NAME OF THE MEDICINAL PRODUCT
Advaquin 500 mg film-coated tablet 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2.	QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet of Advaquin contains 500 mg of levofloxacin as active substance corresponding to 512.46 mg of levofloxacin hemihydrate. 

For excipients, see 6.1 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3.	PHARMACEUTICAL FORM
Advaquin tablets are pink oblong, film coated tablets with break line on both faces.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4. Clinical particulars</strong></p><p><strong>4.1 Therapeutic indications</strong></p><p>Advaquin tablets are indicated in adults for the treatment of the following infections (see sections 4.4 and 5.1):</p><ul><li>Acute pyelonephritis and complicated urinary tract infections (see section 4.4)</li><li>Chronic bacterial prostatitis</li><li>Inhalation Anthrax: postexposure prophylaxis and curative treatment (see section 4.4)</li></ul><p><strong>&nbsp;</strong>In the below-mentioned infections Advaquin tablets should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections.</p><ul><li>Acute bacterial sinusitis</li><li>Acute exacerbations of chronic obstructive pulmonary disease including bronchitis</li><li>Community-acquired pneumonia.</li><li>Complicated skin and soft tissue infections.</li><li>Uncomplicated cystitis (see section 4.4)</li></ul><p>Advaquin tablets may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous levofloxacin.</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.2 Posology and method of administration</strong></p><p>Advaquin tablets &nbsp;are administered once or twice daily. The dosage depends on the type and severity of the infection and the sensitivity of the presumed causative pathogen.</p><p>Advaquin tablets may also be used to complete a course of therapy in patients who have shown<br />improvement during initial treatment with intravenous levofloxacin; given the bioequivalence of theparenteral and oral forms, the same dosage can be used.</p><p><strong>Posology:</strong></p><p>The following dose recommendations can be given for Advaquin tablets :</p><p><em><u>Dosage in patients with normal renal function(creatinine clearance &gt; 50 ml/min)</u></em></p><table border="1" cellspacing="0" cellpadding="0" style="width:632px"><tbody><tr><td style="vertical-align:top"><p><strong>Indication</strong></p></td><td><p><strong>Daily dose regimen (according to severity)</strong></p></td><td><p><strong>Duration of treatment&nbsp;</strong><em>(according to severity)</em></p></td></tr><tr><td><p>Acute bacterial sinusitis</p></td><td><p>500 mg once daily</p></td><td><p>10 - 14 days</p></td></tr><tr><td><p>Acute exacerbations of chronic obstructive pulmonary disease including bronchitis</p></td><td><p>500 mg once daily</p></td><td><p>7 - 10 days</p></td></tr><tr><td><p>Community-acquired pneumonia</p></td><td><p>500 mg once or twice daily</p></td><td><p>7 - 14 days</p></td></tr><tr><td><p>Acute pyelonephritis</p></td><td><p>500 mg once daily</p></td><td><p>7 - 10 days</p></td></tr><tr><td><p>Complicated urinary tract infections</p></td><td><p>500 mg once daily</p></td><td><p>7 - 14 days</p></td></tr><tr><td><p>Uncomplicated cystitis</p></td><td><p>250 mg once daily</p></td><td><p>3 days</p></td></tr><tr><td><p>Chronic bacterial prostatitis</p></td><td><p>500 mg once daily</p></td><td><p>28 days</p></td></tr><tr><td><p>Complicated Skin and soft tissue infections</p></td><td><p>500 mg once or twice daily</p></td><td><p>7 - 14 days</p></td></tr><tr><td><p>Inhalation Anthrax</p></td><td><p>500 mg once daily</p></td><td><p>8 weeks</p></td></tr></tbody></table><p><em><u>&nbsp;</u></em></p><p><em><u>Special Populations</u></em></p><p><strong><em><u>Impaired renal function</u></em></strong><em><u>&nbsp;<strong>(creatinine clearance &le; 50 ml/min)</strong></u></em></p><table border="1" cellspacing="0" cellpadding="0" style="width:632px"><tbody><tr><td rowspan="3"><p><strong>Creatinine clearance</strong></p></td><td colspan="3"><p><strong>Dosage regimen</strong></p></td></tr><tr><td><p><strong>250 mg/24 h</strong></p></td><td><p><strong>500 mg/24 h</strong></p></td><td><p><strong>500 mg/12 h</strong></p></td></tr><tr><td><p>First dose: 250 mg</p></td><td><p>First dose: 500 mg</p></td><td><p>First dose: 500 mg</p></td></tr><tr><td><p>50-20 ml/min</p></td><td><p>Then:125 mg/24h</p></td><td><p>Then: 250 mg/24 h</p></td><td><p>Then:250 mg/12 h</p></td></tr><tr><td><p>19-10 ml/min</p></td><td><p>Then: 125 mg/48 h</p></td><td><p>Then: 125 mg/24 h</p></td><td><p>Then:125 mg/12 h</p></td></tr><tr><td><p>&lt; 10 ml/min (including haemodialysis and CAPD)<sup>1</sup></p></td><td><p>Then: 125 mg/48 h</p></td><td><p>Then: 125 mg/24 h</p></td><td><p>Then:125 mg/24 h</p></td></tr></tbody></table><p><sup>1</sup>&nbsp;No additional doses are required after haemodialysis or continuous ambulatory peritoneal dialysis (CAPD).</p><p><em><u>Impaired liver function</u></em></p><p>No adjustment of dosage is required since levofloxacin is not metabolised to any relevant extent by the liver and is mainly excreted by the kidneys.</p><p><em><u>Elderly population</u></em></p><p>No adjustment of dosage is required in the elderly, other than that imposed by consideration of renal function (see section 4.4 &ldquo;Tendinitis and tendon rupture&rdquo; and &ldquo;QT interval prolongation&rdquo;).</p><p><em><u>Paediatric population</u></em></p><p>Levofloxacin is contraindicated in children and growing adolescents (see section 4.3).</p><p><em><u>Method of administration</u></em></p><p>Advaquin tablets &nbsp;should be swallowed without crushing and with sufficient amount of liquid. They may be divided at the score line to adapt the dose. The tablets may be taken during meals or between meals. Advaquin tablets &nbsp;should be taken at least two hours before or after iron salts, zinc salts, magnesium- or aluminium-containing antacids, or didanosine&nbsp;<em>(only didanosine formulations with aluminium or magnesium containing buffering agents),&nbsp;</em>and sucralfate administration since reduction of absorption can occur (see section 4.5).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                4.3 Contraindications
Advaquin tablets  must not be used:
	In patients hypersensitive to levofloxacin or other quinolones or to any of the excipients listed in section 6.1,
	in patients with epilepsy,
	in patients with history of tendon disorders related to fluoroquinolone administration,
	in children or growing adolescents
	during pregnancy,
	in breast-feeding women.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.4 Special warnings and precautions for use</strong></p><p>The use of levofloxacin should be avoided in patients who have experienced serious adverse reactions in the past when using quinolone or fluoroquinolone containing products (see section 4.8).</p><p>Treatment of these patients with Levofloxacin should only be initiated in the absence of alternative treatment options and after careful benefit/risk assessment (see also section 4.3).</p><p><em>Risks of resistance</em></p><p>Methicillin-resistant S. aureus are very likely to possess co-resistance to fluoroquinolones, including levofloxacin. Therefore levofloxacin is not recommended for the treatment of known or suspected MRSA infections unless laboratory results have confirmed susceptibility of the organism to levofloxacin (and commonly recommended antibacterial agents for the treatment of MRSA-infections are considered inappropriate).</p><p>Levofloxacin may be used in the treatment of Acute Bacterial Sinusitis and Acute Exacerbation of Chronic Bronchitis when these infections have been adequately diagnosed.</p><p>Resistance to fluoroquinolones of E. coli &ndash; the most common pathogen involved in urinary tract infections &ndash; varies across the European Union. Prescribers are advised to take into account the local prevalence of resistance in E. coli to fluoroquinolones.</p><p>Inhalation Anthrax: Use in humans is based on in vitro Bacillus anthracis susceptibility data and on animal experimental data together with limited human data. Treating physicians should refer to national and/or international consensus documents regarding the treatment of anthrax.</p><p>&nbsp;</p><p><em><u>Prolonged, disabling and potentially irreversible serious adverse drug reactions</u></em></p><p><br />Very rare cases of prolonged (continuing months or years), disabling and potentially irreversible<br />serious adverse drug reactions affecting different, sometimes multiple, body systems<br />(musculoskeletal, nervous, psychiatric and senses) have been reported in patients receiving<br />quinolones and fluoroquinolones irrespective of their age and pre-existing risk factors. Levofloxacinshould be discontinued immediately at the first signs or symptoms of any serious adverse reactionand patients should be advised to contact their prescriber for advice</p><p>&nbsp;</p><p><em><u>Tendinitis and tendon rupture</u></em></p><p>Tendinitis and tendon rupture (especially but not limited to Achilles tendon), sometimes bilateral, may occur as early as within 48 hours of starting treatment with quinolones and fluoroquinolones and have been reported to occur even up to several months after discontinuation of treatment in patients receiving daily doses of 1000 mg levofloxacin. The risk of tendinitis and tendon rupture is increased in older patients, patients with renal impairment, patients with solid organ transplants, and those treated concurrently with corticosteroids. Therefore, concomitant use of corticosteroids should be avoided. The daily dose should be adjusted in elderly patients based on creatinine clearance (see section 4.2).</p><p>At the first sign of tendinitis (e.g. painful swelling, inflammation) the treatment with Levofloxacin should be discontinued and alternative treatment should be considered. The affected limb(s) should be appropriately treated (e.g. immobilisation). Corticosteroids should not be used if signs of tendinopathy occur.</p><p><em><u>Clostridium difficile-associated disease</u></em></p><p>Diarrhoea, particularly if severe, persistent and/or bloody, during or after treatment with Levofloxacin (including several weeks after treatment), may be symptomatic of&nbsp;<em>Clostridium difficile</em>-associated disease (CDAD). CDAD may range in severity from mild to life threatening, the most severe form of which is pseudomembranous colitis (see section 4.8). It is therefore important to consider this diagnosis in patients who develop serious diarrhoea during or after treatment with levofloxacin. If CDAD is suspected or confirmed, Advaquin tablets &nbsp;should be stopped immediately and appropriate treatment initiated without delay (e.g. oral metronidazole or vancomycin). Medicinal products inhibiting the peristalsis are contraindicated in this clinical situation.</p><p><em><u>Patients predisposed to seizures</u></em></p><p>Quinolones may lower the seizure threshold and may trigger seizures. Levofloxacin is contraindicated in patients with a history of epilepsy (see section 4.3) and, as with other quinolones, should be used with extreme caution in patients predisposed to seizures, or concomitant treatment with active substances that lower the cerebral seizure threshold, such as theophylline (see section 4.5). In case of convulsive seizures (see section 4.8), treatment with levofloxacin should be discontinued.</p><p><em><u>Patients with G-6- phosphate dehydrogenase deficiency</u></em></p><p>Patients with latent or actual defects in glucose-6-phosphate dehydrogenase activity may be prone to haemolytic reactions when treated with quinolone antibacterial agents. Therefore, if levofloxacin has to be used in these patients, potential occurrence of haemolysis should be monitored.</p><p><em><u>Patients with renal impairment</u></em></p><p>Since levofloxacin is excreted mainly by the kidneys, the dose of Advaquin tablets &nbsp;should be adjusted in patients with renal impairment. (see section 4.2).</p><p><em><u>Hypersensitivity reactions</u></em></p><p>Levofloxacin can cause serious, potentially fatal hypersensitivity reactions (e.g. angioedema to anaphylactic shock), occasionally following the initial dose (see section 4.8). Patients should discontinue treatment immediately and contact their physician or an emergency physician, who will initiate appropriate emergency measures.</p><p><em><u>Severe cutaneous adverse reactions</u></em></p><p>Severe cutaneous adverse reactions (SCARs) including toxic epidermal necrolysis (TEN: also known as Lyell&#39;s syndrome), Stevens Johnson syndrome (SJS) and drug reaction with eosinophilia and systemic symptoms (DRESS), which could be life-threatening or fatal, have been reported with levofloxacin (see section 4.8). At the time of prescription, patients should be advised of the signs and symptoms of severe skin reactions, and be closely monitored. If signs and symptoms suggestive of these reactions appear, levofloxacin should be discontinued immediately and an alternative treatment should be considered. If the patient has developed a serious reaction such as SJS, TEN or DRESS with the use of levofloxacin, treatment with levofloxacin must not be restarted in this patient at any time.</p><p><em><u>Dysglycaemia</u></em></p><p>As with all quinolones, disturbances in blood glucose, including both hypoglycaemia and hyperglycaemia have been reported, usually in diabetic patients receiving concomitant treatment with an oral hypoglycaemic agent (e.g., glibenclamide) or with insulin. Cases of hypoglycaemic coma have been reported. In diabetic patients, careful monitoring of blood glucose is recommended (see section 4.8).</p><p>Advaquin Tablet treatment should be stopped immediately if a patient reports blood glucose disturbance andalternative nonfluoroquinolone antibacterial therapy should be considered</p><p>&nbsp;</p><p><em><u>Prevention of photosensitisation</u></em></p><p>Photosensitisation has been reported with levofloxacin (see section 4.8). It is recommended that patients should not expose themselves unnecessarily to strong sunlight or to artificial UV rays (e.g. sunray lamp, solarium), during treatment and for 48 hours following treatment discontinuation in order to prevent photosensitisation.</p><p><em><u>Patients treated with Vitamin K antagonists</u></em></p><p>Due to possible increase in coagulation tests (PT/INR) and/or bleeding in patients treated with levofloxacin in combination with a vitamin K antagonist (e.g. warfarin), coagulation tests should be monitored when these drugs are given concomitantly (see section 4.5).</p><p><em><u>Psychotic reactions</u></em></p><p>Psychotic reactions have been reported in patients receiving quinolones, including levofloxacin. In very rare cases these have progressed to suicidal thoughts and self-endangering behaviour- sometimes after only a single dose of levofloxacin (see section 4.8). In the event that the patient develops these reactions, levofloxacin should be discontinued and appropriate measures instituted. Caution is recommended if levofloxacin is to be used in psychotic patients or in patients with a history of psychiatric disease.</p><p><strong><u>QT interval prolongation</u></strong></p><p>Caution should be taken when using fluoroquinolones, including levofloxacin, in patients with known risk factors for prolongation of the QT interval such as, for example:</p><p>- Congenital long QT syndrome</p><p>-concomitant use of drugs that are known to prolong the QT interval (e.g. Class IA and III antiarrhythmics, tricyclic antidepressants, macrolides, antipsychotics).</p><p>- uncorrected electrolyte imbalance (e.g. hypokalemia, hypomagnesemia)</p><p>- Cardiac disease (e.g. heart failure, myocardial infarction, bradycardia)</p><p>Elderly patients and women may be more sensitive to QTc-prolonging medications. Therefore, caution should be taken when using fluoroquinolones, including levofloxacin, in these populations.</p><p>(see section 4.2&nbsp;<em>Elderly</em>, section 4.5, section 4.8, section 4.9).</p><p><em><u>Peripheral neuropathy</u></em></p><p>Cases of sensory or sensorimotor polyneuropathy resulting in paraesthesia, hypaesthesia, dysesthesia, or weakness have been reported in patients receiving quinolones and fluoroquinolones.</p><p>Patients under treatment with Levofloxacin should be advised to inform their doctor prior to continuing treatment if symptoms of neuropathy such as pain, burning, tingling, numbness, or weakness develop in order to prevent the development of potentially irreversible condition. (see section 4.8).</p><p><em><u>Hepatobiliary disorders</u></em></p><p>Cases of hepatic necrosis up to fatal hepatic failure have been reported with levofloxacin, primarily in patients with severe underlying diseases, e.g. sepsis (see section 4.8). Patients should be advised to stop treatment and contact their doctor if signs and symptoms of hepatic disease develop such as anorexia, jaundice, dark urine, pruritus or tender abdomen.</p><p><em><u>Exacerbation of myasthenia gravis</u></em></p><p>Fluoroquinolones, including levofloxacin, have neuromuscular blocking activity and may exacerbate muscle weakness in patients with myasthenia gravis. Postmarketing serious adverse reactions, including deaths and the requirement for respiratory support, have been associated with fluoroquinolone use in patients with myasthenia gravis. Levofloxacin is not recommended in patients with a known history of myasthenia gravis.</p><p><em><u>Vision disorders</u></em></p><p>If vision becomes impaired or any effects on the eyes are experienced, an eye specialist should be consulted immediately (see sections 4.7 and 4.8).</p><p><em><u>Superinfection</u></em></p><p>The use of levofloxacin, especially if prolonged, may result in overgrowth of non-susceptible organisms. If superinfection occurs during therapy, appropriate measures should be taken.</p><p><em>Interference with laboratory tests</em></p><p>In patients treated with levofloxacin, determination of opiates in urine may give false-positive results. It may be necessary to confirm positive opiate screens by more specific method.</p><p>Levofloxacin may inhibit the growth of&nbsp;<em>Mycobacterium tuberculosis&nbsp;</em>and, therefore, may give false-negative results in the bacteriological diagnosis of tuberculosis.</p><p><em>Aortic Aneurysm and Dissection</em></p><p>Epidemiologic studies report an increased risk of aortic aneurysm and dissection after intake of fluoroquinolones, particularly in the older population.</p><p>Therefore, fluoroquinolones should only be used after careful benefit-risk assessment and after consideration of other therapeutic options in patients with positive family history of aneurysm disease, or in patients diagnosed with pre-existing aortic aneurysm and/or aortic dissection, or in presence of other risk factors or conditions predisposing for aortic aneurysm and dissection (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, Takayasu arteritis, giant cell arteritis, Behcet&#39;s disease, hypertension, known atherosclerosis).</p><p>In case of sudden abdominal, chest or back pain, patients should be advised to immediately consult a physician in an emergency department.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.5 Interaction with other medicinal products and other forms of interaction</strong></p><p><em><u>Effect of other medicinal products on </u></em><em><u>Advaquin Tablets</u></em></p><p><em><u>Iron salts, zinc salts, magnesium- or aluminium-containing antacids, didanosine</u></em></p><p>Levofloxacin absorption is significantly reduced when iron salts, or magnesium- or aluminium-containing antacids, or didanosine (only didanosine formulations with aluminium or magnesium containing buffering agents) are administered concomitantly with Advaquin tablets . Concurrent administration of fluoroquinolones with multi-vitamins containing zinc appears to reduce their oral absorption. It is recommended that preparations containing divalent or trivalent cations such as iron salts, zinc salts or magnesium- or aluminium-containing antacids, or didanosine (<em>only</em>&nbsp;<em>didanosine formulations with aluminium or magnesium containing buffering agents)</em>&nbsp;should not be taken 2 hours before or after Advaquin tablets &nbsp;administration (see section 4.2). Calcium salts have a minimal effect on the oral absorption of levofloxacin.</p><p><em><u>Sucralfate</u></em></p><p>The bioavailability of Advaquin tablets &nbsp;is significantly reduced when administered together with sucralfate. If the patient is to receive both sucralfate and Advaquin tablets , it is best to administer sucralfate 2 hours after the Advaquin tablets &nbsp;administration (see section 4.2).</p><p><em><u>Theophylline, fenbufen or similar non-steroidal anti-inflammatory drugs</u></em></p><p>No pharmacokinetic interactions of levofloxacin were found with theophylline in a clinical study. However a pronounced lowering of the cerebral seizure threshold may occur when quinolones are given concurrently with theophylline, non-steroidal anti-inflammatory drugs, or other agents which lower the seizure threshold.</p><p>Levofloxacin concentrations were about 13 % higher in the presence of fenbufen than when administered alone.</p><p><em><u>Probenecid and cimetidine</u></em></p><p>Probenecid and cimetidine had a statistically significant effect on the elimination of levofloxacin. The renal clearance of levofloxacin was reduced by cimetidine (24 %) and probenecid (34 %). This is because both drugs are capable of blocking the renal tubular secretion of levofloxacin. However, at the tested doses in the study, the statistically significant kinetic differences are unlikely to be of clinical relevance.</p><p>Caution should be exercised when levofloxacin is coadministered with drugs that effect the tubular renal secretion such as probenecid and cimetidine, especially in renally impaired patients.</p><p><em><u>Other relevant information</u></em></p><p>Clinical pharmacology studies have shown that the pharmacokinetics of levofloxacin were not affected to any clinically relevant extent when levofloxacin was administered together with the following drugs:</p><p>- calcium carbonate</p><p>- digoxin</p><p>- glibenclamide</p><p>- ranitidine.</p><p><em><u>Effect of levofloxacin on other medicinal products</u></em></p><p><em><u>Ciclosporin</u></em></p><p>The half-life of ciclosporin was increased by 33 % when coadministered with levofloxacin.</p><p><em><u>Vitamin K antagonists</u></em></p><p>Increased coagulation tests (PT/INR) and/or bleeding, which may be severe, have been reported in patients treated with levofloxacin in combination with a vitamin K antagonist (e.g. warfarin). Coagulation tests, therefore, should be monitored in patients treated with vitamin K antagonists (see section 4.4).</p><p><em><u>Drugs known to prolong the QT interval</u></em></p><p>Levofloxacin, like other fluoroquinolones, should be used with caution in patients receiving drugs known to prolong the QT interval (e.g. Class IA and III antiarrhythmics, tricyclic antidepressants, macrolides, antipsychotic). (See section 4.4 QT interval prolongation).</p><p>&nbsp;</p><p><em><u>Other&nbsp;</u></em><em><u>relevant information</u></em></p><p><u>In a pharmacokinetic interaction study, levofloxacin did not affect the pharmacokinetics of theophylline (which is a probe substrate for CYP1A2), indicating that levofloxacin is not a CYP1A2 inhibitor.</u></p><p>&nbsp;</p><p><em><u>Other forms of interactions</u></em></p><p><em><u>Food</u></em></p><p>There is no clinically relevant interaction with food. Advaquin tablets &nbsp;may therefore be administered regardless of food intake.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.6 Fertility, pregnancy and lactation</strong></p><p><em><u>Pregnancy</u></em></p><p>There are limited amount of data with respect to the use of levofloxacin in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3). However in the absence of human data and due to that experimental data suggest a risk of damage by fluoroquinolones to the weight-bearing cartilage of the growing organism, levofloxacin must not be used in pregnant women (see sections 4.3 and 5.3).</p><p><em><u>Breast-feeding</u></em></p><p>Advaquin tablets &nbsp;are contraindicated in breast-feeding women. There is insufficient information on the excretion of levofloxacin in human milk; however other fluoroquinolones are excreted in breast milk. In the absence of human data and due to that experimental data suggest a risk of damage by fluoroquinolones to the weight-bearing cartilage of the growing organism, levofloxacin must not be used in breast-feeding women (see sections 4.3 and 5.3).</p><p><em><u>Fertility</u></em></p><p>Levofloxacin caused no impairment of fertility or reproductive performance in rats.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.7 Effects on ability to drive and use machines</strong></p><p>Some undesirable effects (e.g. dizziness/vertigo, drowsiness, visual disturbances) may impair the patient&#39;s ability to concentrate and react, and therefore may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or operating machinery).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.8 Undesirable effects</strong></p><p>The information given below is based on data from clinical studies in more than 8300 patients and on extensive post marketing experience.</p><p>Frequencies are defined using the following convention: very common (&ge; 1/10), common (&ge; 1/100, &lt; 1/10), uncommon (&ge; 1/1,000, &lt; 1/100), rare (&ge; 1/10,000, &lt; 1/1,000), very rare (&lt; 1/10,000), not known (cannot be estimated from the available data).</p><p>Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p><strong>System organ class</strong></p></td><td style="vertical-align:top"><p><strong>Common</strong></p><p><strong>(&ge;1/100 to &lt;1/10 )</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon</strong></p><p><strong>(&ge;1/1,000 to &lt;1/100)</strong></p></td><td style="vertical-align:top"><p><strong>Rare</strong></p><p><strong>(&ge;1/10,000 to &lt;1/1,000)</strong></p></td><td style="vertical-align:top"><p><strong>Not known</strong></p><p><strong>(cannot be estimated from available data)</strong></p></td></tr><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Fungal infection including Candida infection</p><p>Pathogen resistance</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Leukopenia</p><p>Eosinophilia</p></td><td style="vertical-align:top"><p>Thrombocytopenia</p><p>Neutropenia</p></td><td style="vertical-align:top"><p>Pancytopenia</p><p>Agranulocytosis</p><p>Haemolytic anaemia</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Angioedema</p><p>Hypersensitivity (see section 4.4)</p></td><td style="vertical-align:top"><p>Anaphylactic shock<sup>a</sup></p><p>Anaphylactoid shock&nbsp;<sup>a</sup>&nbsp;(see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Anorexia</p></td><td style="vertical-align:top"><p>Hypoglycaemia particularly in diabetic patients (see section 4.4)</p></td><td style="vertical-align:top"><p>Hyperglycaemia</p><p>Hypoglycaemic coma (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders*</p></td><td style="vertical-align:top"><p>Insomnia</p></td><td style="vertical-align:top"><p>Anxiety</p><p>Confusional state</p><p>Nervousness</p></td><td style="vertical-align:top"><p>Psychotic reactions (with e.g. hallucination, paranoia)</p><p>Depression</p><p>Agitation</p><p>Abnormal dreams</p><p>Nightmares</p></td><td style="vertical-align:top"><p>Psychotic disorders with self-endangering behaviour including suicidal ideation or suicide attempt (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders*</p></td><td style="vertical-align:top"><p>Headache</p><p>Dizziness</p></td><td style="vertical-align:top"><p>Somnolence</p><p>Tremor</p><p>Dysgeusia</p></td><td style="vertical-align:top"><p>Convulsion (see sections 4.3 and 4.4)</p><p>Paraesthesia</p></td><td style="vertical-align:top"><p>Peripheral sensory neuropathy (see section 4.4)</p><p>Peripheral sensory motor neuropathy (see section 4.4)</p><p>Parosmia including anosmia</p><p>Dyskinesia</p><p>Extrapyramidal disorder</p><p>Ageusia</p><p>Syncope</p><p>Benign intracranial hypertension</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders*</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Visual disturbances such as blurred vision (see section 4.4)</p></td><td style="vertical-align:top"><p>Transient vision loss (see section 4.4), uveitis</p></td></tr><tr><td style="vertical-align:top"><p>Ear and Labyrinth disorders*</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Vertigo</p></td><td style="vertical-align:top"><p>Tinnitus</p></td><td style="vertical-align:top"><p>Hearing loss</p><p>Hearing impaired</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Tachycardia, Palpitation</p></td><td style="vertical-align:top"><p>Ventricular tachycardia, which may result in cardiac arrest</p><p>Ventricular arrhythmia and torsade de pointes (reported predominantly in patients with risk factors of QT prolongation), electrocardiogram QT prolonged (see sections 4.4 and 4.9)</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Hypotension</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Dyspnoea</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Bronchospasm</p><p>Pneumonitis allergic</p></td></tr><tr><td style="vertical-align:top"><p>Gastro-intestinal disorders</p></td><td style="vertical-align:top"><p>Diarrhoea</p><p>Vomiting</p><p>Nausea</p></td><td style="vertical-align:top"><p>Abdominal pain</p><p>Dyspepsia</p><p>Flatulence</p><p>Constipation</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Diarrhoea &ndash; haemorrhagic which in very rare cases may be indicative of enterocolitis, including pseudomembranous colitis (see section 4.4)</p><p>Pancreatitis</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Hepatic enzyme increased (ALT/AST, alkaline phosphatase, GGT)</p></td><td style="vertical-align:top"><p>Blood bilirubin increased</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Jaundice and severe liver injury, including cases with fatal acute liver failure, primarily in patients with severe underlying diseases (see section 4.4)</p><p>Hepatitis</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders&nbsp;<sup>b</sup></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Rash</p><p>Pruritus</p><p>Urticaria</p><p>Hyperhidrosis</p></td><td style="vertical-align:top"><p>Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) (see section 4.4), Fixed drug eruption</p></td><td style="vertical-align:top"><p>Toxic epidermal necrolysis</p><p>Stevens-Johnson syndrome</p><p>Erythema multiforme</p><p>Photosensitivity reaction (see section 4.4)</p><p>Leukocytoclasticvasculitis</p><p>Stomatitis</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Arthralgia</p><p>Myalgia</p></td><td style="vertical-align:top"><p>Tendon disorders (see sections 4.3 and 4.4) including tendinitis (e.g. Achilles tendon)</p><p>Muscular weakness which may be of special importance in patients with myasthenia gravis (see section 4.4 )</p></td><td style="vertical-align:top"><p>Rhabdomyolysis</p><p>Tendon rupture (e.g. Achilles tendon) (see sections 4.3 and 4.4)</p><p>Ligament rupture</p><p>Muscle rupture</p><p>Arthritis</p></td></tr><tr><td style="vertical-align:top"><p>Renal and Urinary disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Blood creatinine increased</p></td><td style="vertical-align:top"><p>Renal failure acute (e.g. due to interstitial nephritis)</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions*</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Asthenia</p></td><td style="vertical-align:top"><p>Pyrexia</p></td><td style="vertical-align:top"><p>Pain (including pain in back, chest, and extremities)</p></td></tr></tbody></table><p><sup>a</sup>&nbsp;Anaphylactic and anaphylactoid reactions may sometimes occur even after the first dose</p><p><sup>b</sup>&nbsp;Mucocutaneous reactions may sometimes occur even after the first dose</p><p>*Very rare cases of prolonged (up to months or years), disabling and potentially irreversible serious drug reactions affecting several, sometimes multiple, system organ classes and senses (including reactions such as tendonitis, tendon rupture, arthralgia, pain in extremities, gait disturbance, neuropathies associated with paraesthesia, depression, fatigue, memory impairment, sleep disorders, and impairment of hearing, vision, taste and smell) have been reported in association with the use of quinolones and fluoroquinolones in some cases irrespective of pre-existing risk factors (see Section 4.4).</p><p><strong>Reporting of suspected adverse reactions</strong></p><p>Please refer to leaflet for ADR reporting address.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.9 Overdose</strong></p><p>According to toxicity studies in animals or clinical pharmacology studies performed with supra-therapeutic doses, the most important signs to be expected following acute overdosage of levofloxacin are central nervous system symptoms such as confusion, dizziness, impairment of consciousness, and convulsive seizures, increases in QT interval as well as gastro-intestinal reactions such as nausea and mucosal erosions.</p><p>CNS effects including confusional state, convulsion, hallucination, and tremor have been observed in post marketing experience.</p><p>In the event of overdose, symptomatic treatment should be implemented. ECG monitoring should be undertaken, because of the possibility of QT interval prolongation. Antacids may be used for protection of gastric mucosa. Haemodialysis, including peritoneal dialysis and CAPD, are not effective in removing levofloxacin from the body. No specific antidote exists.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>5. Pharmacological properties</strong></p><p><strong>5.1 Pharmacodynamic properties</strong></p><p><strong>Pharmacotherapeutic group:</strong>&nbsp;Antiifectives for systemic use &ndash; Antibacterials for systemic use &ndash; Quinolone antibasterials &ndash; Fluoroquinolones</p><p><strong>ATC code:</strong>&nbsp;J01MA12</p><p>Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class and is the S (-) enantiomer of the racemic drug substance ofloxacin.</p><p><strong><em>Mechanism of action</em></strong></p><p>As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA-DNA-gyrase complex and topoisomerase IV.</p><p><strong><em>PK/PD relationship</em></strong></p><p>The degree of the bactericidal activity of levofloxacin depends on the ratio of the maximum concentration in serum (C<sub>max</sub>) or the area under the curve (AUC) and the minimal inhibitory concentration (MIC).</p><p><strong><em>Mechanism(s) of resistance</em></strong></p><p>Resistance to levofloxacin is acquired through a stepwise process by target site mutations in both type II topoisomerases, DNA gyrase and topoisomerase IV. Other resistance mechanisms such as permeation barriers (common in Pseudomonas aeruginosa) and efflux mechanisms may also affect susceptibility to levofloxacin.</p><p><em>Cross</em>-resistance between levofloxacin and other fluoroquinolones<em>&nbsp;is observed.&nbsp;</em>Due to the mechanism of action, there is generally no cross-resistance between levofloxacin and other classes of antibacterial agents.</p><p><em><u>Breakpoints</u></em></p><p>The EUCAST recommended MIC breakpoints for levofloxacin, separating susceptible from intermediately susceptible organisms and intermediately susceptible from resistant organisms are presented in the below table for MIC testing (mg/L).</p><p><em>EUCAST clinical MIC breakpoints for levofloxacin (version 2.0, 2012-01-01):</em></p><table border="1" cellspacing="0" cellpadding="0" style="width:560px"><tbody><tr><td><p><strong>Pathogen</strong></p></td><td><p><strong>Susceptible</strong></p></td><td><p><strong>Resistant</strong></p></td></tr><tr><td><p>Enterobacteriacae</p></td><td><p>&le;1 mg/L</p></td><td><p>&gt;2 mg/L</p></td></tr><tr><td><p><em>Pseudomonas spp.</em></p></td><td><p>&le;1 mg/L</p></td><td><p>&gt;2 mg/L</p></td></tr><tr><td><p><em>Acinetobacter spp.</em></p></td><td><p>&le;1 mg/L</p></td><td><p>&gt;2 mg/L</p></td></tr><tr><td><p><em>Staphylococcus spp.</em></p></td><td><p>&le;1 mg/L</p></td><td><p>&gt;2 mg/L</p></td></tr><tr><td><p><em>S.pneumoniae</em>&nbsp;<sup>1</sup></p></td><td><p>&le;2 mg/L</p></td><td><p>&gt;2 mg/L</p></td></tr><tr><td><p><em>Streptococcus A,B,C,G</em></p></td><td><p>&le;1 mg/L</p></td><td><p>&gt;2 mg/L</p></td></tr><tr><td><p><em>H.influenzae</em><sup>2, 3&nbsp;</sup><em>M.catarrhalis</em>&nbsp;<sup>3</sup></p></td><td><p>&le;1 mg/L</p></td><td><p>&gt;1 mg/L</p></td></tr><tr><td><p>Non-species related breakpoints&nbsp;<sup>4</sup></p></td><td><p>&le;1 mg/L</p></td><td><p>&gt;2 mg/L</p></td></tr></tbody></table><p><sup>1</sup>. The breakpoints for levofloxacin relate to high dose therapy.</p><p>2. Low-level fluoroquinolone resistance (ciprofloxacin MICs of 0.12-0.5 mg/l) may occur but there is no evidence that this resistance is of clinical importance in respiratory tract infections with&nbsp;<em>H. influenzae</em>.</p><p>3. Strains with MIC values above the susceptible breakpoint are very rare or not yet reported. The identification and antimicrobial susceptibility tests on any such isolate must be repeated and if the result is confirmed the isolate must be sent to a reference laboratory. Until there is evidence regarding clinical response for confirmed isolates with MIC above the current resistant breakpoint they should be reported resistant.</p><p>4. Breakpoints apply to an oral dose of 500 mg x 1 to 500 mg x 2 and an intravenous dose of 500 mg x 1 to 500 mg x 2.</p><p>The prevalence of resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><table border="1" cellspacing="0" cellpadding="0" style="width:626px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Commonly susceptible species</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Aerobic Gram-positive bacteria</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Bacillus anthracis</p><p>Staphylococcus aureus methicillin-susceptible</p><p>Staphylococcus saprophyticus</p><p>Streptococci, group C and G</p><p>Streptococcus agalactiae</p><p>Streptococcus pneumoniae</p><p>Streptococcus pyogenes</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Aerobic Gram- negative bacteria</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Eikenellacorrodens</p><p>Haemophilus influenzae</p><p>Haemophilus para-influenzae</p><p>Klebsiella oxytoca</p><p>Moraxella catarrhalis</p><p>Pasteurellamultocida</p><p>Proteus vulgaris</p><p>Providenciarettgeri</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Anaerobic bacteria</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Peptostreptococcus</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Other</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Chlamydophila pneumoniae</p><p>Chlamydophilapsittaci</p><p>Chlamydia trachomatis</p><p>Legionella pneumophila</p><p>Mycoplasma pneumoniae</p><p>Mycoplasma hominis</p><p>Ureaplasmaurealyticum</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Species for which acquired resistance may be a problem</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Aerobic Gram-positive bacteria</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Enterococcus faecalis</p><p>Staphylococcus aureus methicillin-resistant<sup>#</sup></p><p>Coagulase negative Staphylococcus spp</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Aerobic Gram- negative bacteria</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Acinetobacterbaumannii</p><p>Citrobacterfreundii</p><p>Enterobacteraerogenes</p><p>Enterobacter cloacae</p><p>Escherichia coli</p><p>Klebsiella pneumoniae</p><p>Morganellamorganii</p><p>Proteus mirabilis</p><p>Providenciastuartii</p><p>Pseudomonas aeruginosa</p><p>Serratiamarcescens</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Anaerobic bacteria</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Bacteroidesfragilis</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Inherently resistant Strains</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Aerobic Gram-positive bacteria</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Enterococcus faecium</p></td></tr></tbody></table><p># Methicillin-resistant S. aureus are very likely to possess co-resistance to fluoroquinolones, including levofloxacin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>5.2 Pharmacokinetic properties</strong></p><p><em><u>Absorption</u></em></p><p>Orally administered levofloxacin is rapidly and almost completely absorbed with peak plasma concentrations being obtained within 1- 2 h. The absolute bioavailability is 99- 100 %.</p><p>Food has little effect on the absorption of levofloxacin.</p><p>Steady state conditions are reached within 48 hours following a 500 mg once or twice daily dosage regimen.</p><p><em><u>Distribution</u></em></p><p>Approximately 30 - 40 % of levofloxacin is bound to serum protein. The mean volume of distribution of levofloxacin is approximately 100 l after single and repeated 500 mg doses, indicating widespread distribution into body tissues.</p><p><em><u>Penetration into tissues and body fluids:</u></em></p><p><em>Levofloxacin has been shown to penetrate</em>&nbsp;into bronchial mucosa<em>,</em>&nbsp;epithelial lining fluid, alveolar macrophages, lung tissue<em>, skin (</em>blister fluid<em>), prostatic tissue and urine. However, levofloxacin has&nbsp;</em>poor penetration intro cerebro-spinal fluid.</p><p><em><u>Biotransformation</u></em></p><p>Levofloxacin is metabolised to a very small extent, the metabolites being desmethyl-levofloxacin and levofloxacin N-oxide. These metabolites account for &lt; 5 % of the dose excreted in urine. Levofloxacin is stereochemically stable and does not undergo chiral inversion.</p><p><em><u>Elimination</u></em></p><p>Following oral and intravenous administration of levofloxacin, it is eliminated relatively slowly from the plasma (t<sub>&frac12;</sub>: 6 - 8 h). Excretion is primarily by the renal route &gt; 85 % of the administered dose).</p><p>The mean apparent total body clearance of levofloxacin following a 500 mg single dose was 175 +/-29.2 ml/min.</p><p>There are no major differences in the pharmacokinetics of levofloxacin following intravenous and oral administration, suggesting that the oral and intravenous routes are interchangeable.</p><p><em><u>Linearity</u></em></p><p>Levofloxacin obeys linear pharmacokinetics over a range of 50 to 1000 mg.</p><p><strong>Special populations</strong></p><p><em><u>Subjects with renal insufficiency</u></em></p><p>The pharmacokinetics of levofloxacin are affected by renal impairment. With decreasing renal function renal elimination and clearance are decreased, and elimination half-lives increased as shown in the table below:</p><p>Pharmacokinetics in renal insufficiency following single oral 500 mg dose</p><table border="1" cellspacing="0" cellpadding="0" style="width:632px"><tbody><tr><td style="vertical-align:top"><p>Cl<sub>cr</sub>&nbsp;[ml/min]</p></td><td style="vertical-align:top"><p>&lt; 20</p></td><td style="vertical-align:top"><p>20 - 49</p></td><td style="vertical-align:top"><p>50 - 80</p></td></tr><tr><td style="vertical-align:top"><p>Cl<sub>R</sub>&nbsp;[ml/min]</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>26</p></td><td style="vertical-align:top"><p>57</p></td></tr><tr><td style="vertical-align:top"><p>t<sub>1/2</sub>&nbsp;[h]</p></td><td style="vertical-align:top"><p>35</p></td><td style="vertical-align:top"><p>27</p></td><td style="vertical-align:top"><p>9</p></td></tr></tbody></table><p><em><u>Elderly subjects</u></em></p><p>There are no significant differences in levofloxacin kinetics between young and elderly subjects, except those associated with differences in creatinine clearance.</p><p><em><u>Gender differences</u></em></p><p>Separate analysis for male and female subjects showed small to marginal gender differences in levofloxacin pharmacokinetics. There is no evidence that these gender differences are of clinical relevance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>5.3 Preclinical safety data</strong></p><p>Non-clinical data reveal no special hazard for humans based on conventional studies of single dose toxicity, repeated dose toxicity, carcinogenic potential and toxicity to reproduction and development.</p><p>Levofloxacin caused no impairment of fertility or reproductive performance in rats and its only effect on fetuses was delayed maturation as a result of maternal toxicity.</p><p>Levofloxacin did not induce gene mutations in bacterial or mammalian cells but did induce chromosome aberrations in Chinese hamster lung cells in vitro. These effects can be attributed to inhibition of topoisomerase II.<em>&nbsp;In vivo&nbsp;</em>tests (micronucleus, sister chromatid exchange, unscheduled DNA synthesis, dominant lethal tests) did not show any genotoxic potential.</p><p>Studies in the mouse showed levofloxacin to have phototoxic activity only at very high doses. Levofloxacin did not show any genotoxic potential in a photomutagenicity assay, and it reduced tumour development in a photocarcinogenity study.</p><p>In common with other fluoroquinolones, levofloxacin showed effects on cartilage (blistering and cavities) in rats and dogs. These findings were more marked in young animals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>6. Pharmaceutical particulars</strong></p><p><strong>6.1 List of excipients</strong></p><p>Microcrystalline cellulose, maize starch, powdered cellulose, pregelatinized starch, crospovidone, povidone K-25, sodium stearylfumarate, opadry pink and purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>6.2 Incompatibilities</strong></p><p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                6.3 Shelf life
2 years

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>6.4 Special precautions for storage</strong></p><p>Store below 30&deg;C in a dry place.</p><p>Protect from light and moisture.</p><p>Keep out of the reach of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>6.5 Nature and contents of container</strong></p><p>Aluminium/PVC film</p><p>Pack size of 1 x 5&rsquo;s</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>6.6 Special precautions for disposal and other handling</strong></p><p>A score line allows adaptation of the dose in patients with impaired renal function.</p><p>As for all medicines, any unused medicinal product should be disposed of accordingly and in compliance with local environmental regulations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                7. MARKETING AUTHORISATION HOLDER
OMAN PHARMACEUTICAL PRODUCTS CO. L.L.C. Salalah, Sultanate of Oman

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                April 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>